FCF TMT Market Study 2021 – published
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF TMT Market Study – 2021”.. Based on available data from European TMT companies, the FCF TMT Market Study is a detailed and comprehensive
How SMEs should reorganize their financing now | WirtschaftsWoche 27.10.2021 – Quotes by FCF
How SMEs should reorganize their financing now | WirtschaftsWoche 27.10.2021 – Quotes by FCF WirtschaftsWoche reports on October 27, 2021 on the topic of SME financing after the Corona crisis. Various experts are quoted and
Negative life sciences sentiments recorded in September 2021
In the course of the monthly published FCF Life Sciences Venture Capital Monitor – Europe, the FCF Life Sciences team analyses the current sentiments in European life sciences venture capital funding per subsector. In September
FCF Biotech Venture Capital Monitor – USA 09/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 09/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Valuation Monitor – Q3 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q3 2021”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
FCF Life Sciences Venture Capital Monitor – Europe 09/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 09/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life
FCF Metals & Materials Market Study – 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Metals & Materials Market Study – 2021”. FCF regularly engages in research on the metals & materials sector based on available data from
FCF Life Sciences acts as sole financial advisor to Precisis AG in a EUR 20m financing round with Cochlear Ltd.
Munich, 11th October 2021 – FCF Life Sciences, part of FCF Fox Corporate Finance GmbH, acts as sole financial advisor to Precisis AG, a leading neurostimulation company, in the execution of a financing transaction of
FCF European Chemicals Market Study – 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF European Chemicals Market Study – 2021”. FCF regularly engages in research on the chemicals sector based on available data from European chemical firms.
FCF Biotech Venture Capital Monitor – USA 08/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 08/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
